FDA Panel Recommends Covid-19 Vaccine. What Would Approval Mean For Markets?
December 10, 2020 4:49 PM Taylor Tepper - Forbes Advisor
Posted:
Updated:
December 12, 2020 7:01 AM
As expected, a Food and Drug Administration (FDA) advisory panel has recommended Emergency Use Authorization (EUA) for the Pfizer/BioNTech Covid-19 vaccine in the United States. This clears the way for FDA approval of the vaccine within days.
Once approved by the FDA, Pfizer will deliver hundreds of millions of doses over the coming months. The FDA will likely approve Moderna’s Covid-19 vaccine in a separate EUA next week.
There are miles to go before life returns to normal, however. Hundreds of thousands have died, millions are out of work, and countless Americans are waiting for state governments to lift lockdowns and Congress to pass another stimulus package.
Channel3000.com
December 10, 2020 7:52 AM Taylor Tepper - Forbes Advisor
Posted:
Updated:
You’d think 2020
would not be the year Airbnb chose to go public.
After years of will-they-or-won’t-they drama, the online home rental giant is finally selling shares to the public. Airbnb’s IPO is seeing a surprising level of demand, and the company recently disclosed a much higher valuation than it had just a few months ago despite another round of Covid-19 lockdowns and travel restrictions.
With promising coronavirus vaccines and a potential return to normality on the horizon, does Airbnb have the right stuff to survive and thrive in public markets? Here are five stats that can help you make sense of the Airbnb IPO.